143 related articles for article (PubMed ID: 33465437)
1. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
[TBL] [Abstract][Full Text] [Related]
2. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
[TBL] [Abstract][Full Text] [Related]
3. Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models.
Liao M; Xie Q; Zhao Y; Yang C; Lin C; Wang G; Liu B; Zhu L
Pharmacol Res; 2022 Feb; 176():106077. PubMed ID: 35026404
[TBL] [Abstract][Full Text] [Related]
4. Si-Miao-Yong-An Decoction attenuates isoprenaline-induced myocardial fibrosis in AMPK-driven Akt/mTOR and TGF-β/SMAD3 pathways.
Zhao Y; Sun D; Chen Y; Zhan K; Meng Q; Zhang X; Zhu L; Yao X
Biomed Pharmacother; 2020 Oct; 130():110522. PubMed ID: 32736236
[TBL] [Abstract][Full Text] [Related]
5. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice.
Ren Y; Chen X; Li P; Zhang H; Su C; Zeng Z; Wu Y; Xie X; Wang Q; Han J; Guo S; Liu B; Wang W
Pharmacol Res; 2019 Aug; 146():104318. PubMed ID: 31228552
[TBL] [Abstract][Full Text] [Related]
6. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
Wu Y; Wang BX; Guo YY; Wang YQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):284-8. PubMed ID: 26387199
[TBL] [Abstract][Full Text] [Related]
7. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
[TBL] [Abstract][Full Text] [Related]
8. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
[TBL] [Abstract][Full Text] [Related]
10. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291
[TBL] [Abstract][Full Text] [Related]
11. Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy.
Zhao LG; Li PL; Dai Y; Deng JL; Shan MY; Chen B; Zhang KB; Guo SD; Xu ZH
J Cardiovasc Pharmacol; 2020 Aug; 76(2):246-254. PubMed ID: 32433360
[TBL] [Abstract][Full Text] [Related]
12. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
13. YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI
Wan M; Yin K; Yuan J; Ma S; Xu Q; Li D; Gao H; Gou X
J Ethnopharmacol; 2022 Mar; 285():114835. PubMed ID: 34798161
[TBL] [Abstract][Full Text] [Related]
14. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
16. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
[TBL] [Abstract][Full Text] [Related]
17. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potential pharmacodynamic ingredients of Dang-Gui-Si-Ni decoction based on absorbed ingredients and molecular docking.
Li Y; Liu SS; Guo ZY; Yi H; Li C; Chen LM; Gao HM; Yan LH; Zhang WW; Feng XX; Zhao JY; Liu XQ; Wang ZM
J Ethnopharmacol; 2021 Jul; 275():114045. PubMed ID: 33831463
[TBL] [Abstract][Full Text] [Related]
19. Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation.
Su C; Wang Q; Zhang H; Jiao W; Luo H; Li L; Chen X; Liu B; Yu X; Li S; Wang W; Guo S
Front Pharmacol; 2019; 10():990. PubMed ID: 31619988
[No Abstract] [Full Text] [Related]
20. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
